Insider Transactions in Q1 2025 at Ptc Therapeutics, Inc. (PTCT)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 08
2025
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
SELL
Open market or private sale
|
Indirect |
107
-1.76%
|
$4,708
$44.5 P/Share
|
|
Jan 08
2025
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
SELL
Open market or private sale
|
Direct |
1,552
-1.48%
|
$68,288
$44.5 P/Share
|
|
Jan 08
2025
|
Mark Elliott Boulding EXEC. VP AND CLO |
SELL
Open market or private sale
|
Direct |
1,998
-1.84%
|
$87,912
$44.5 P/Share
|
|
Jan 08
2025
|
Lee Scott Golden EVP & CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,198
-1.5%
|
$52,712
$44.5 P/Share
|
|
Jan 08
2025
|
Matthew B. Klein CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
2,402
-0.84%
|
$105,688
$44.5 P/Share
|
|
Jan 08
2025
|
Eric Pauwels CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
2,136
-2.4%
|
$93,984
$44.5 P/Share
|
|
Jan 08
2025
|
Christine Marie Utter SVP, CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
1,662
-2.52%
|
$73,128
$44.5 P/Share
|
|
Jan 07
2025
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
SELL
Open market or private sale
|
Indirect |
55
-0.9%
|
$2,475
$45.34 P/Share
|
|
Jan 07
2025
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
SELL
Open market or private sale
|
Direct |
1,265
-1.19%
|
$56,925
$45.34 P/Share
|
|
Jan 07
2025
|
Mark Elliott Boulding EXEC. VP AND CLO |
SELL
Open market or private sale
|
Direct |
1,543
-1.4%
|
$69,435
$45.34 P/Share
|
|
Jan 07
2025
|
Lee Scott Golden EVP & CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
810
-1.0%
|
$36,450
$45.34 P/Share
|
|
Jan 07
2025
|
Matthew B. Klein CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
2,142
-0.74%
|
$96,390
$45.34 P/Share
|
|
Jan 07
2025
|
Eric Pauwels CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
1,599
-1.77%
|
$71,955
$45.34 P/Share
|
|
Jan 07
2025
|
Christine Marie Utter SVP, CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
1,291
-1.92%
|
$58,095
$45.34 P/Share
|
|
Jan 03
2025
|
Matthew B. Klein CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
70,000
+19.53%
|
-
|
|
Jan 03
2025
|
Pierre Gravier CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
22,500
+22.67%
|
-
|
|
Jan 03
2025
|
Eric Pauwels CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
22,000
+19.55%
|
-
|
|
Jan 03
2025
|
Lee Scott Golden EVP & CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+19.87%
|
-
|
|
Jan 03
2025
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
BUY
Grant, award, or other acquisition
|
Indirect |
715
+10.43%
|
-
|
|
Jan 03
2025
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
19,000
+15.19%
|
-
|
|
Jan 03
2025
|
Mark Elliott Boulding EXEC. VP AND CLO |
BUY
Grant, award, or other acquisition
|
Direct |
18,000
+14.02%
|
-
|
|
Jan 03
2025
|
Christine Marie Utter SVP, CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
14,000
+17.23%
|
-
|
|
Jan 03
2025
|
Michael Schmertzler |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+5.74%
|
-
|
|
Jan 03
2025
|
Allan Steven Jacobson |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+16.43%
|
-
|
|
Jan 03
2025
|
Stephanie Okey |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+22.39%
|
-
|
|
Jan 03
2025
|
Emma Reeve |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+20.83%
|
-
|
|
Jan 03
2025
|
Mary L. Smith |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+18.34%
|
-
|
|
Jan 03
2025
|
David P Southwell |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+19.18%
|
-
|
|
Jan 03
2025
|
Glenn Jr Md Phd Steele |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+17.78%
|
-
|
|
Jan 03
2025
|
Jerome B Zeldis |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+17.78%
|
-
|
|
Jan 03
2025
|
Alethia Young |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+18.99%
|
-
|